Dr. Reddy’s Laboratories launches generic version of antiviral Valcyte

HYDERABAD, India — Dr. Reddy’s Laboratories announced Tuesday that it has launched Valganciclovir Tablets USP 450 mg, a therapeutic equivalent generic version of the antiviral Valcyte (Valganciclovir) tablets, in the U.S. market.

 

The Valcyte (Valganciclovir) tablets brand had U.S. sales of approximately $440 million for the most recent 12 months ending in October 2014, according to IMS Health, Dr. Reddy's announced.

 

Dr. Reddy’s Valganciclovir tablets, USP in 450 mg is available in bottle counts of 60.